Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer
Clinical trial NCT02291913 · COMPLETED
Trial details
- NCT number
- NCT02291913
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-18
- Primary completion
- 2019-01-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.